$68.57
1.76%
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US8342032005
Symbol
SLNO

Soleno Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Soleno Therapeutics Inc Classifications & Recommendation:

Buy
93%
Hold
7%

Soleno Therapeutics Inc Price Target

Target Price $117.30
Price $68.57
Potential
Number of Estimates 11
11 Analysts have issued a price target Soleno Therapeutics Inc 2026 . The average Soleno Therapeutics Inc target price is $117.30. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 14 Analysts recommend Soleno Therapeutics Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Soleno Therapeutics Inc stock has an average upside potential 2026 of . Most analysts recommend the Soleno Therapeutics Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 0.00 111.45

11 Analysts have issued a sales forecast Soleno Therapeutics Inc 2025 . The average Soleno Therapeutics Inc sales estimate is

$111m
Unlock
. This is
241.24% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$176m 440.11%
Unlock
, the lowest is
$23.1m 29.14%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $0.0
2026
$345m 209.31%
Unlock
2027
$629m 82.53%
Unlock

12 Soleno Therapeutics Inc Analysts have issued a net profit forecast 2025. The average Soleno Therapeutics Inc net profit estimate is

$-162m
Unlock
. This is
10.75% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-135m 25.42%
Unlock
, the lowest is
$-177m 2.28%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-176m 351.01%
2025
$-162m 8.10%
Unlock
2026
$62.5m 138.64%
Unlock
2027
$271m 334.03%
Unlock

Net Margin

2026
18.11% 112.49%
Unlock
2027
43.08% 137.88%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -4.38 -3.20
85.59% 26.94%
P/E negative
EV/Sales 30.57

12 Analysts have issued a Soleno Therapeutics Inc forecast for earnings per share. The average Soleno Therapeutics Inc EPS is

$-3.20
Unlock
. This is
10.61% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-2.68 25.14%
Unlock
, the lowest is
$-3.51 1.96%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-4.38 85.59%
2025
$-3.20 26.94%
Unlock
2026
$1.24 138.75%
Unlock
2027
$5.37 333.06%
Unlock

P/E ratio

Current -19.15 33.18%
2025
-21.40 11.73%
Unlock
2026
55.39 358.83%
Unlock
2027
12.76 76.96%
Unlock

Based on analysts' sales estimates for 2025, the Soleno Therapeutics Inc stock is valued at an EV/Sales of

30.57
Unlock
and an P/S ratio of
32.70
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 104.32
2025
30.57 70.69%
Unlock
2026
9.88 67.67%
Unlock
2027
5.41 45.21%
Unlock

P/S ratio

Current
2025
32.70 70.70%
Unlock
2026
10.57 67.67%
Unlock
2027
5.79 45.21%
Unlock

Current Soleno Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
Locked
Locked Aug 20 2025
HC Wainwright & Co.
Locked
Locked
Locked Aug 18 2025
Guggenheim
Locked
Locked
Locked Aug 07 2025
Oppenheimer
Locked
Locked
Locked Aug 07 2025
Baird
Locked
Locked
Locked Jul 11 2025
Baird
Locked
Locked
Locked May 08 2025
Guggenheim
Locked
Locked
Locked May 08 2025
Analyst Rating Date
Locked
Wells Fargo:
Locked
Locked
Aug 20 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Aug 18 2025
Locked
Guggenheim:
Locked
Locked
Aug 07 2025
Locked
Oppenheimer:
Locked
Locked
Aug 07 2025
Locked
Baird:
Locked
Locked
Jul 11 2025
Locked
Baird:
Locked
Locked
May 08 2025
Locked
Guggenheim:
Locked
Locked
May 08 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today